Development of an Automated Tool for the Estimation of Histological Remission in Ulcerative Colitis Using Single-Wavelength Endoscopy Technology - Scorecard - MDSpire

Development of an Automated Tool for the Estimation of Histological Remission in Ulcerative Colitis Using Single-Wavelength Endoscopy Technology

  • By

  • Pieter Sinonquel

  • Matthias Lenfant

  • Tom Eelbode

  • Hiroki Watanabe

  • Belian Callaerts

  • Peter Bossuyt

  • Bram Verstockt

  • João Pedro Guedelha Sabino

  • Gert De Hertogh

  • Frederik Maes

  • Séverine Vermeire

  • Raf Bisschops

  • November 27, 2024

  • 0 min

Share

Clinical Scorecard: Creation of an Automated System for Assessing Histological Remission in Ulcerative Colitis Utilizing Single-Wavelength Endoscopy Techniques

At a Glance

CategoryDetail
ConditionUlcerative colitis (UC)
Key MechanismsAssessment of histological remission via microvascular changes detected by single-wavelength endoscopy (SWE) and computer-aided diagnosis (CAD) using deep learning
Target PopulationPatients with histologically confirmed UC with minimum disease duration of 3 months
Care SettingEndoscopy units performing colonoscopy or flexible sigmoidoscopy

Key Highlights

  • SWE-CAD model demonstrated superior diagnostic accuracy (95.2%) for histological remission compared to WLE-CAD (67.5%)
  • SWE uses 410 nm monochromatic light to visualize mucosal microvasculature and subtle histological inflammation in vivo
  • Automated CAD reduces inter-reader variability and provides objective assessment of histological remission in UC

Guideline-Based Recommendations

Diagnosis

  • Use colonoscopy or flexible sigmoidoscopy with both WLE and SWE imaging modalities for UC disease activity assessment
  • Obtain biopsies at imaged sites for histological confirmation using Geboes score
  • Apply CAD models trained on SWE images to estimate histological remission non-invasively

Management

  • Target histological remission as a treatment goal in UC management
  • Incorporate SWE-CAD assessment to guide therapeutic decisions by accurately detecting histological activity

Monitoring & Follow-up

  • Perform regular endoscopic evaluations with SWE imaging to monitor mucosal healing and histological remission
  • Use CAD outputs to reduce variability and improve consistency in disease activity monitoring

Risks

  • Potential for misclassification with WLE alone due to limited sensitivity and specificity for histological activity
  • Standard biopsy risks apply during tissue sampling for histological confirmation

Patient & Prescribing Data

Patients with UC undergoing endoscopic evaluation

Accurate detection of histological remission via SWE-CAD may optimize treatment adjustments and improve long-term outcomes by targeting deeper mucosal healing

Clinical Best Practices

  • Utilize high-definition endoscopes capable of both WLE and SWE imaging for comprehensive mucosal assessment
  • Ensure biopsy sampling is precisely correlated with imaging locations to validate CAD findings
  • Train and validate CAD models on large datasets to enhance diagnostic performance
  • Incorporate SWE-CAD assessment into routine clinical workflows to reduce inter-observer variability

References

Original Source(s)

Related Content